LPCN Lipocine Inc. logo

LPCN Lipocine Inc.

Healthcare
$2.26+1.80%ClosedMarket Cap: $13.1M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

3

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+173,000

Shares Acquired

173,000

Shares Disposed

0

Total Bought ($)

$3.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Apr 07Higuchi John W.directorBuy40,000$2.03203,797
Mon Apr 06Patel Mahesh V.director, officer: Chief Executive OfficerBuy25,000$2.03160,679
Mon Apr 06Higuchi John W.directorBuy123,000$2.05163,797
Thu Apr 02Patel Mahesh V.director, officer: Chief Executive OfficerBuy25,000$2.02135,679
Mon Jan 05Patel Mahesh V.director, officer: Chief Executive OfficerSell25,000$8.00182,668
Fri Dec 19Patel Mahesh V.director, officer: Chief Executive OfficerSell8,629$4.20157,668
Fri Dec 19Fogarty Kristaofficer: Principal Accounting OfficerSell20,786$4.2040,146
Thu Jun 05Papapetropoulos SpyrosdirectorSell1,764$3.207,174
Thu Jun 05Ono Richard DanadirectorSell1,764$3.2011,526
Thu Jun 05Jene Jill M.directorSell1,764$3.207,174
Thu Jun 05Higuchi John W.directorSell1,764$3.2011,526
Thu Jun 05Fink Jeffrey ArvindirectorSell1,764$3.2011,526
Thu Jan 02Patel Mahesh V.director, officer: Chief Executive OfficerSell16,371$4.86149,039
Thu Jan 02Patel Mahesh V.director, officer: Chief Executive OfficerSell10,320$4.80132,688